Analyze Diet
Journal of veterinary pharmacology and therapeutics1990; 13(1); 76-80; doi: 10.1111/j.1365-2885.1990.tb00750.x

Pharmacokinetics of tinidazole in the horse.

Abstract: Serum tinidazole concentrations were monitored in five clinically healthy adult horses after intravenous (i.v.) and oral administration of the drug (15 mg/kg and 25 mg/kg, respectively). After i.v. administration, the mean residence time was 7.0 h, the elimination half-life 5.2 h and the body clearance rate 1.6 ml/min/kg. The distribution volume was found to be 660 ml/kg. After oral administration, the mean residence time was 8.5 h, the absorption half-life 1.1 h and the bioavailability essentially 100%. In view of the in-vitro sensitivities of various anaerobic bacteria, a dosage of 10-15 mg/kg of tinidazole, orally, at 12-h intervals, can be recommended for the treatment of anaerobic infections in horses.
Publication Date: 1990-03-01 PubMed ID: 2319639DOI: 10.1111/j.1365-2885.1990.tb00750.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studied how the drug tinidazole is absorbed, distributed, and eliminated in horses when given both orally and intravenously. The findings suggest that a 10-15 mg/kg dose given orally every 12 hours could effectively treat anaerobic bacterial infections in horses.

Pharmacokinetics of Tinidazole

The research investigated the pharmacokinetics of tinidazole, an antimicrobial drug, in horses. The pharmacokinetics refers to the process of drug absorption, distribution, metabolism, and excretion within a living organism.

  • The study involved five healthy adult horses, and the researchers administered tinidazole both intravenously (i.v.) and orally, with dosage rates of 15 mg/kg and 25 mg/kg respectively.
  • The findings were reported in terms of mean residence time (the average time the drug remains in the body), elimination half-life (the time it takes for the body to eliminate half of the drug dosage), body clearance rate (the volume of blood from which the drug is completely removed per unit time), and bioavailability (the proportion of the drug that enters the circulation).
  • For intravenous administration, the mean residence time was 7.0 hours, the elimination half-life was 5.2 hours, and the body clearance rate was 1.6 ml/min/kg. These figures give an indication of how quickly the drug is processed and eliminated from the body when administered directly into the bloodstream.
  • For oral administration, the mean residence time was 8.5 hours, the absorption half-life was 1.1 hours, and the bioavailability was essentially 100%. This suggests that the drug is fully absorbed into the bloodstream when given orally and remains in the body longer compared to intravenous administration.
  • The determination of pharmacokinetic parameters is crucial in establishing the correct dosage and frequency of drug administration to achieve therapeutic effectiveness while minimizing the potential side effects.

Treatment Recommendation

On the basis of the in-vitro (outside the organism) sensitivities of various anaerobic bacteria and the pharmacokinetic findings, the researchers recommended a dosage of 10-15 mg/kg of tinidazole, given orally at 12-hour intervals, for the treatment of anaerobic infections in horses. It’s worth noting that this recommendation requires further validation through clinical trials to ensure its safety and efficacy in a practical setting.

Cite This Article

APA
Pyörälä S, Kotilainen T, Silvennoinen P, Hänninen U, Mero M, Kaartinen L. (1990). Pharmacokinetics of tinidazole in the horse. J Vet Pharmacol Ther, 13(1), 76-80. https://doi.org/10.1111/j.1365-2885.1990.tb00750.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 13
Issue: 1
Pages: 76-80

Researcher Affiliations

Pyörälä, S
  • Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Hautjärvi, Finland.
Kotilainen, T
    Silvennoinen, P
      Hänninen, U
        Mero, M
          Kaartinen, L

            MeSH Terms

            • Administration, Oral
            • Animals
            • Bacteroides / drug effects
            • Clostridium / drug effects
            • Female
            • Fusobacterium / drug effects
            • Half-Life
            • Horses / metabolism
            • Injections, Intravenous / veterinary
            • Male
            • Metabolic Clearance Rate
            • Microbial Sensitivity Tests
            • Nitroimidazoles / pharmacokinetics
            • Time Factors
            • Tinidazole / administration & dosage
            • Tinidazole / blood
            • Tinidazole / pharmacokinetics

            Citations

            This article has been cited 0 times.